REGENERX BIOPHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Regenerx Biopharmaceuticals Inc Return On Equity for the quarter ending March 31, 2023 was 51.2 %, a 35.9% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Return On Equity for 2022 was 57.5 %, a 21.1% decline from 2021.
  • Regenerx Biopharmaceuticals Inc annual Return On Equity for 2021 was 72.9 %, a 31.1% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Return On Equity for 2020 was 55.6 %, a 19.9% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 57.5 -15.3 -21.1% Jan 1, 2022 Dec 31, 2022
2021 72.9 +17.3 +31.1% Jan 1, 2021 Dec 31, 2021
2020 55.6 -13.8 -19.9% Jan 1, 2020 Dec 31, 2020
2019 69.4 -25.3 -26.7% Jan 1, 2019 Dec 31, 2019
2018 94.7 +100 Jan 1, 2018 Dec 31, 2018
2017 -5.27 -2.22 -72.7% Jan 1, 2017 Dec 31, 2017
2016 -3.05 -102 -103% Jan 1, 2016 Dec 31, 2016
2015 98.9 -49.3 -33.3% Jan 1, 2015 Dec 31, 2015
2014 148 +104 +238% Jan 1, 2014 Dec 31, 2014
2013 43.8 -47.7 -52.1% Jan 1, 2013 Dec 31, 2013
2012 91.5 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.